{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"1.330","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"2,035,724,910","primaryexch":"HKEX","ric":"1521.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":4.0E-4,"inline_upper_strike_price":"","sedol":"BKDQKL5","am":"1.22","iv":"","ew_strike":"","as":"1.280","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"1.250","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"2,000","update_time":"2025-09-26 10:38:37.0","lo52":"0.500","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Li Song","underlying_ric":"1521.HK","hi52":"1.870","issuer_name":"Frontage Holdings Corporation","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"1.230","mkt_cap":"2.54","f_aum_hkd":null,"ew_sub_per_to":"","ls":"1.250","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0.000","aum":"","issued_shares_class_B":null,"vo":"944.00","secondary_listing_flag":false,"listing_date":"30 May 2019","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Frontage Holdings Corporation","nm_s":"FRONTAGE","sym":"1521","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"Frontage Holdings Corporation is a holding company. It provides laboratory and related services to pharmaceutical and agrochemical companies, as well as bioequivalence clinical and chemical services. The Company has two main divisions: Global Laboratory Services and Global Drug Discovery & Development Services. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. The Global Drug Discovery & Development Services division includes Drug Development Unit, the Drug Discovery Unit, and the Pharmaceutical Product Development Unit. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Drug Development Unit includes drug metabolism and pharmacokinetics, Safety and Toxicology. The Company's segments include North America and Europe and PRC.","op":"1.280","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"Room 1920, 19/F<br/>Lee Garden One<br/>33 Hysan Avenue<br/>Causeway Bay, Hong Kong","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"403.23","eps_ccy":"USD","hdr":false,"launch_date":"","hc":"1.250","isin":"KYG3679P1019","moneyness":""}},"qid":"1758890625352"}
